过去一年中添加的文章,按日期排序
Research progress of PROTACs for neurodegenerative diseases therapy
45 天前 - … , including Alzheimer's disease, Parkinson's disease, and Huntington's disease,
fall … system and have emerged as a novel and efficacious approach in drug discovery. …
fall … system and have emerged as a novel and efficacious approach in drug discovery. …
Theranostic Application of Nanomaterial in Human Health and Disease
48 天前 - … The use of inorganic nanoparticles in drug delivery is another emerging field for
the treatment of some diseases. Some of the well-established inorganic nanomaterials for …
the treatment of some diseases. Some of the well-established inorganic nanomaterials for …
[HTML][HTML] Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles
X Liu, L Shen, M Wan, H Xie, Z Wang - Journal of Nanobiotechnology, 2024 - Springer
51 天前 - … At the vanguard of emerging mechanisms are extracellular vesicles (EVs), nano- to
… This review aims to elucidate the emerging narrative of extracerebral-derived EVs as dual …
… This review aims to elucidate the emerging narrative of extracerebral-derived EVs as dual …
[HTML][HTML] Clearing the Fog: A Review of Antipsychotics for Parkinson's-Related Hallucinations: A Focus on Pimavanserin, Quetiapine and Clozapine
T Abdul-Rahman, RE Herrera-Calderón… - Journal of Integrative …, 2024 - imrpress.com
51 天前 - … Parkinson’s disease psychosis (PDP). However, careful consideration is necessary
when selecting the most appropriate drug … application are still emerging and relatively recent…
when selecting the most appropriate drug … application are still emerging and relatively recent…
Revolutionizing Neurological Disorder Treatment: Integrating Innovations in Pharmaceutical Interventions and Advanced Therapeutic Technologies.
R Arora, A Baldi - Current Pharmaceutical Design, 2024 - europepmc.org
54 天前 - … disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke. This review
explores emerging trends in drug … , the development of innovative drug delivery systems, and …
explores emerging trends in drug … , the development of innovative drug delivery systems, and …
[HTML][HTML] … of Cannabidiol Lipid Nanoparticles in Alleviating Metabolic and Memory Impairments and Hippocampal Histopathological Changes in Diabetic Parkinson's …
S Lapmanee, S Bhubhanil, P Wongchitrat… - Pharmaceutics, 2024 - mdpi.com
55 天前 - … This aligns with the emerging field of nanomedicine, where nanoparticles
enhance drug delivery efficiency and may contribute to improved treatment outcomes [19,45,63,64]. …
enhance drug delivery efficiency and may contribute to improved treatment outcomes [19,45,63,64]. …
[HTML][HTML] The Gut Microbiota in Parkinson Disease: Interactions with Drugs and Potential for Therapeutic Applications
E Menozzi, AHV Schapira - CNS drugs, 2024 - Springer
59 天前 - … The concept of a ‘microbiota-gut-brain axis’ has recently emerged as an important
player in the pathophysiology of Parkinson disease (PD), not least because of the reciprocal …
player in the pathophysiology of Parkinson disease (PD), not least because of the reciprocal …
[HTML][HTML] NRF2 in Neurological Disorders: A Molecular Beacon for Therapeutics
N Verma - 2024 - intechopen.com
59 天前 - … This chapter delves into the emerging role of the NRF2 transcription factor as a …
Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and …
Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and …
[HTML][HTML] Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications
PM Giri, A Banerjee, A Ghosal, B Layek - International Journal of …, 2024 - mdpi.com
60 天前 - … Furthermore, numerous emerging pieces of evidence have demonstrated that
inflammation not only supports the progression of NDs but can also serve as an initiator. Hence, …
inflammation not only supports the progression of NDs but can also serve as an initiator. Hence, …
Ropinirole Withdrawal in a 67-Year-Old Male: A Case Report
N Notta, SN Notta, A Jagadish, HM Magacha, R Shah - 2024 - dc.etsu.edu
60 天前 - … leg syndrome (RLS) and Parkinson's disease. Ropinirole is a dopamine agonist that
… emotional lability, and a headache, emerging approximately 2-3 weeks after discontinuing …
… emotional lability, and a headache, emerging approximately 2-3 weeks after discontinuing …